메뉴 건너뛰기




Volumn 18, Issue 2, 2011, Pages

25 years of pharmacoepidemiologic innovation: The saskatchewan health administrative databases

Author keywords

[No Author keywords available]

Indexed keywords

PRESCRIPTION DRUG; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; SULFONYLUREA;

EID: 79959820669     PISSN: 1198581X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (12)

References (31)
  • 1
    • 0022370157 scopus 로고
    • A record linkage study of valproate and malformations in Saskatchewan
    • West R, Sherman GJ, Downey W. A record linkage study of valproate and malformations in Saskatchewan. Can J Public Health 1985;76:226-8.
    • (1985) Can J Public Health , vol.76 , pp. 226-228
    • West, R.1    Sherman, G.J.2    Downey, W.3
  • 2
    • 85041244576 scopus 로고    scopus 로고
    • International Society for Pharmacoepidemiology, Bethesda, MD: International Society for Pharmacoepidemiology, 2011, January 27, 2011
    • International Society for Pharmacoepidemiology. Bethesda, MD: International Society for Pharmacoepidemiology, 2011. http://www.pharmacoepi.org/ (January 27, 2011).
  • 3
    • 12644304498 scopus 로고
    • Getting down to bases - record linkage in Saskatchewan
    • Tilson HH. Getting down to bases - record linkage in Saskatchewan. Can J Public Health 1985;76:222-3.
    • (1985) Can J Public Health , vol.76 , pp. 222-223
    • Tilson, H.H.1
  • 6
    • 79956264199 scopus 로고    scopus 로고
    • Regina: Saskatchewan Ministry of Health, November, January 27, 2011
    • Health services databases: information document. Regina: Saskatchewan Ministry of Health, November 2010. http://www.health.gov.sk.ca/Default.aspx?DN=21 03410e-ad99-4bf5-ba42-dc07b16f45a6 (January 27, 2011).
    • (2010) Health Services Databases: Information Document
  • 7
    • 0026595475 scopus 로고
    • The use of beta-agonists and the risk of death and near death from asthma
    • Spitzer WO, Suissa S, Ernst P, et al. The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med 1992;326:501-6.
    • (1992) N Engl J Med , vol.326 , pp. 501-506
    • Spitzer, W.O.1    Suissa, S.2    Ernst, P.3
  • 8
    • 0030055844 scopus 로고    scopus 로고
    • New evidence on benzodiazepine use and falls: The time factor
    • Neutel CI, Hirdes JP, Maxwell CJ, Patten SB. New evidence on benzodiazepine use and falls: the time factor. Age Ageing 1996;25:273-8.
    • (1996) Age Ageing , vol.25 , pp. 273-278
    • Neutel, C.I.1    Hirdes, J.P.2    Maxwell, C.J.3    Patten, S.B.4
  • 9
    • 31544482787 scopus 로고    scopus 로고
    • Dose-response relation between sulfonylurea drugs and mortality in type 2 diabetes mellitus: A population-based cohort study
    • Simpson SH, Majumdar SR, Tsuyuki RT, Eurich DT, Johnson JA. Dose-response relation between sulfonylurea drugs and mortality in type 2 diabetes mellitus: a population-based cohort study. Can Med Assoc J 2006;174:169-74.
    • (2006) Can Med Assoc J , vol.174 , pp. 169-174
    • Simpson, S.H.1    Majumdar, S.R.2    Tsuyuki, R.T.3    Eurich, D.T.4    Johnson, J.A.5
  • 10
    • 0023902341 scopus 로고
    • Fatal upper gastrointestinal hemorrhage or perforation among users and non-users of non-steroidal anti-inflammatory drugs in Saskatchewan, Canada, 1983
    • Guess HA, West R, Strand LM, et al. Fatal upper gastrointestinal hemorrhage or perforation among users and non-users of non-steroidal anti-inflammatory drugs in Saskatchewan, Canada, 1983. J Clin Epidemiol 1988;41:35-45.
    • (1988) J Clin Epidemiol , vol.41 , pp. 35-45
    • Guess, H.A.1    West, R.2    Strand, L.M.3
  • 11
    • 70349739937 scopus 로고    scopus 로고
    • Cardiovascular risks of non-steroidal anti-inflammatory drugs in patients after hospitalization for serious coronary heart disease
    • Ray WA, Varas-Lorenzo C, Chung C, et al. Cardiovascular risks of non-steroidal anti-inflammatory drugs in patients after hospitalization for serious coronary heart disease. Circ Cardiovasc Qual Outcomes 2009;2:155-63.
    • (2009) Circ Cardiovasc Qual Outcomes , vol.2 , pp. 155-163
    • Ray, W.A.1    Varas-Lorenzo, C.2    Chung, C.3
  • 13
  • 14
    • 0032445461 scopus 로고    scopus 로고
    • Hospitalizations for aplastic anemia and agranulocytosis in Saskatchewan: Incidence and associations with antecedent prescription drug use
    • Rawson NSB, Rutledge Harding S, Malcolm E, Lueck L. Hospitalizations for aplastic anemia and agranulocytosis in Saskatchewan: incidence and associations with antecedent prescription drug use. J Clin Epidemiol 1998;51:1343-55.
    • (1998) J Clin Epidemiol , vol.51 , pp. 1343-1355
    • Rawson, N.S.B.1    Rutledge Harding, S.2    Malcolm, E.3    Lueck, L.4
  • 15
    • 0032854375 scopus 로고    scopus 로고
    • The risk of serious cardiac arrhythmias among cisapride users in the United Kingdom and Canada
    • Walker AM, Szneke P, Bianchi Weatherby L, et al. The risk of serious cardiac arrhythmias among cisapride users in the United Kingdom and Canada. Am J Med 1999;107:356-62.
    • (1999) Am J Med , vol.107 , pp. 356-362
    • Walker, A.M.1    Szneke, P.2    Bianchi Weatherby, L.3
  • 16
    • 77955651041 scopus 로고    scopus 로고
    • Persistence with cholinesterase inhibitor therapy in a population-based cohort of patients with Alzheimer's disease
    • Amuah JE, Hogan DB, Eliasziw M, et al. Persistence with cholinesterase inhibitor therapy in a population-based cohort of patients with Alzheimer's disease. Pharmacoepidemiol Drug Saf 2010;19:670-9.
    • (2010) Pharmacoepidemiol Drug Saf , vol.19 , pp. 670-679
    • Amuah, J.E.1    Hogan, D.B.2    Eliasziw, M.3
  • 17
    • 36549071661 scopus 로고    scopus 로고
    • Primer: Administrative health databases in observational studies of drug effects-advantages and disadvantages
    • Suissa S, Garbe E. Primer: administrative health databases in observational studies of drug effects-advantages and disadvantages. Nat Clin Pract Rheumatol 2007;3:725-32.
    • (2007) Nat Clin Pract Rheumatol , vol.3 , pp. 725-732
    • Suissa, S.1    Garbe, E.2
  • 18
    • 85041254797 scopus 로고    scopus 로고
    • Data, data, everywhere: improving access to population health and healthservices research data in Canada - final report, Vancouver: Centre for Health Services and Policy Research, April January 27, 2011
    • Black C, McGrail K, Fooks C, Baranek P, Maslove L. Data, data, everywhere: improving access to population health and healthservices research data in Canada - final report. Vancouver: Centre for Health Services and Policy Research, April 2005: 40. http://www.chspr.ubc.ca/files/publications/2005/ch spr05-12R.pdf (January 27, 2011).
    • (2005) , vol.40
    • Black, C.1    McGrail, K.2    Fooks, C.3    Baranek, P.4    Maslove, L.5
  • 19
    • 70549098878 scopus 로고    scopus 로고
    • Access to linked administrative healthcare utilization data for pharmacoepidemiology and pharmacoeconomics research in Canada: Anti-viral drugs as an example
    • Rawson NSB. Access to linked administrative healthcare utilization data for pharmacoepidemiology and pharmacoeconomics research in Canada: anti-viral drugs as an example. Pharmacoepidemiol Drug Saf 2009;18:1072-9.
    • (2009) Pharmacoepidemiol Drug Saf , vol.18 , pp. 1072-1079
    • Rawson, N.S.B.1
  • 20
    • 0032417801 scopus 로고    scopus 로고
    • Assessing the validity of diagnostic information in administrative health care utilization data: Experience in Saskatchewan
    • Rawson NSB, D'Arcy C. Assessing the validity of diagnostic information in administrative health care utilization data: experience in Saskatchewan. Pharmacoepidemiol Drug Saf 1998;7:389-98.
    • (1998) Pharmacoepidemiol Drug Saf , vol.7 , pp. 389-398
    • Rawson, N.S.B.1    D'arcy, C.2
  • 21
    • 0033029198 scopus 로고    scopus 로고
    • Validity of stroke diagnosis on hospital discharge records in Saskatchewan, Canada: Implications for stroke surveillance
    • Liu L, Reeder B, Shuaib A, Mazagri R. Validity of stroke diagnosis on hospital discharge records in Saskatchewan, Canada: implications for stroke surveillance. Cerebrovasc Dis 1999;9:224-30.
    • (1999) Cerebrovasc Dis , vol.9 , pp. 224-230
    • Liu, L.1    Reeder, B.2    Shuaib, A.3    Mazagri, R.4
  • 22
    • 0033646775 scopus 로고    scopus 로고
    • Concordance on the recording of cancer in the Saskatchewan Cancer Agency registry, hospital charts and death registrations
    • Rawson NSB, Robson DL. Concordance on the recording of cancer in the Saskatchewan Cancer Agency registry, hospital charts and death registrations. Can J Public Health 2000;91:390-3.
    • (2000) Can J Public Health , vol.91 , pp. 390-393
    • Rawson, N.S.B.1    Robson, D.L.2
  • 24
    • 50249104815 scopus 로고    scopus 로고
    • Positive predictive value of ICD-9 codes 410 and 411 in the identification of cases of acute coronary syndromes in the Saskatchewan hospital automated database
    • Varas-Lorenzo C, Castellsague J, Stang MR, Tomas L, Aguado J, Perez-Gutthann S. Positive predictive value of ICD-9 codes 410 and 411 in the identification of cases of acute coronary syndromes in the Saskatchewan hospital automated database. Pharmacoepidemiol Drug Saf 2008;17:842-52.
    • (2008) Pharmacoepidemiol Drug Saf , vol.17 , pp. 842-852
    • Varas-Lorenzo, C.1    Castellsague, J.2    Stang, M.R.3    Tomas, L.4    Aguado, J.5    Perez-Gutthann, S.6
  • 26
    • 37449019447 scopus 로고    scopus 로고
    • Manitoba and Saskatchewan administrative health care utilization databases are used differently to answer epidemiologic research questions
    • Tricco AC, Pham B, Rawson NSB. Manitoba and Saskatchewan administrative health care utilization databases are used differently to answer epidemiologic research questions. J Clin Epidemiol 2008;61:192-7.
    • (2008) J Clin Epidemiol , vol.61 , pp. 192-197
    • Tricco, A.C.1    Pham, B.2    Rawson, N.S.B.3
  • 29
    • 33750459877 scopus 로고    scopus 로고
    • Epidemiology in the pharmaceutical industry: A Canadian perspective
    • Rawson NSB, De Souza LR. Epidemiology in the pharmaceutical industry: a Canadian perspective. Pharmacoepidemiol Drug Saf 2006;15:758-62.
    • (2006) Pharmacoepidemiol Drug Saf , vol.15 , pp. 758-762
    • Rawson, N.S.B.1    de Souza, L.R.2
  • 30
    • 85041256448 scopus 로고    scopus 로고
    • (DSEN). Ottawa: Canadian Institutes of Health Research, January 27, 2011
    • Drug Safety and Effectiveness Network (DSEN). Ottawa: Canadian Institutes of Health Research, 2010. http://www.cihrirsc.gc.ca/e/40269.html (January 27, 2011).
    • (2010)
    • Safety, D.1
  • 31
    • 0035570262 scopus 로고    scopus 로고
    • Ethical issues in pharmacoepidemiologic research using Saskatchewan administrative health care utilization data
    • Rawson NSB. Ethical issues in pharmacoepidemiologic research using Saskatchewan administrative health care utilization data. Pharmacoepidemiol Drug Saf 2001;10:607-12.
    • (2001) Pharmacoepidemiol Drug Saf , vol.10 , pp. 607-612
    • Rawson, N.S.B.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.